Related Experiment Videos
Control of heparin therapy with an activated partial thromboplastin time
The Netherlands Journal of Medicine
|January 1, 1973
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Role of isoleucine residues 182 and 183 in thrombin-activatable fibrinolysis inhibitor.
Journal of thrombosis and haemostasis : JTH·2005
Decreased plasma sensitivity to activated protein C by oral contraceptives is associated with decreases in plasma glucosylceramide.
Journal of thrombosis and haemostasis : JTH·2005
Tumor growth and metastasis are not affected in thrombin-activatable fibrinolysis inhibitor-deficient mice.
Journal of thrombosis and haemostasis : JTH·2004
Impaired healing of cutaneous wounds and colonic anastomoses in mice lacking thrombin-activatable fibrinolysis inhibitor.
Journal of thrombosis and haemostasis : JTH·2003
Thrombin-activatable fibrinolysis inhibitor (TAFI, plasma procarboxypeptidase B, procarboxypeptidase R, procarboxypeptidase U).
Journal of thrombosis and haemostasis : JTH·2003
A diagnostic tool for self-poisoned patients: Analysis of gastric content and lavage fluids.
The Netherlands journal of medicine·2020
Hypokalaemia and peripheral oedema in a Cushingoid patient with metastatic prostate cancer.
The Netherlands journal of medicine·2020
An uncommon side effect of thiamazole treatment in Graves' disease.
The Netherlands journal of medicine·2020
Renal insufficiency due to an orthohantavirus infection in the north of the Netherlands.
The Netherlands journal of medicine·2020
Brain lesions in a patient with rectal cancer: mind your step.
The Netherlands journal of medicine·2020
Fendrix® compared to Engerix® in HIV-infected patients nonresponding to initial- and re-vaccination schedule.
The Netherlands journal of medicine·2020
Does Tranexamic acid fix all bleeding in surgery?
Journal of the National Medical Association·2026
Pharmacokinetics, Elimination and Dialyzability of HRS-9231 in Patients with Varying Degrees of Renal Impairment.
Clinical pharmacokinetics·2026